Cargando…
Effective delivery of large genes to the retina by dual AAV vectors
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. However, AAV's limited cargo capacity prevents its application to therapies of inherited retinal diseases due to mutations of genes over 5 kb, like Stargardt's disease (STGD) and Usher syndrome...
Autores principales: | Trapani, Ivana, Colella, Pasqualina, Sommella, Andrea, Iodice, Carolina, Cesi, Giulia, de Simone, Sonia, Marrocco, Elena, Rossi, Settimio, Giunti, Massimo, Palfi, Arpad, Farrar, Gwyneth J, Polishchuk, Roman, Auricchio, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927955/ https://www.ncbi.nlm.nih.gov/pubmed/24150896 http://dx.doi.org/10.1002/emmm.201302948 |
Ejemplares similares
-
Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease
por: Trapani, Ivana, et al.
Publicado: (2015) -
Recombinant Vectors Based on Porcine Adeno-Associated Viral Serotypes Transduce the Murine and Pig Retina
por: Puppo, Agostina, et al.
Publicado: (2013) -
Triple Vectors Expand AAV Transfer Capacity in the Retina
por: Maddalena, Andrea, et al.
Publicado: (2018) -
Inclusion of a degron reduces levelsof undesired inteins after AAV-mediated proteintrans-splicing in the retina
por: Tornabene, Patrizia, et al.
Publicado: (2021) -
Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy
por: Colella, Pasqualina, et al.
Publicado: (2013)